DOCSLIB.ORG

Thursday 14Thnovember

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Thursday 14Thnovember Thursday 14thNovember The Royal Institution 21Albemarle Street, Mayfair London presented by longevity, beyond the have thepower to effect change. Thisis also audiences of this Forum and the promotion the reason why the Forum decided to host of a positive agenda around longevity, is its first Longevity Week as an extension of critical. the mission of the Forum, and we thank all the global strategic partners and supporters We believe that in the next decade there who made this possible. is the potential for a step change in both the policy and attitudes which are required The Global Agenda, one of the Forumʼs LONGEVITY 2030 for societies to reap a significant longevity flagshipinitiatives developed in conjunction dividend and maximise the return on with the Stanford Center on Longevity and The Next Ten Years longevity. launched at a Longevity Week event in Singapore earlier this week, embodies the This is why the theme of this yearʼs Forum global nature of the opportunities at hand. and Longevity Week is Longevity 2030 – a It follows a high-level meeting of experts deeper dive into the ideas and innovations co-hosted by The Longevity Forum earlier that will shape humanity in the next 10years. this year around the concept of ʻA New Welcome to The Longevity Forum Our agenda is ambitious,but it matches the Map of Lifeʼ. This initiative outlined the level of change that we expect to see over principles which make longevity distinct 2019,our second annual Forum the next decade. Already we can see how from ageing and set high level objectives the longevity agenda is advancing in the which governments around the world need and the closing event of our first UK on many fronts. to achieve in the next 10 years to support the longevity agenda. Longevity Week. This yearʼs Forum will explore the ever- expanding boundaries of science and Following last yearʼs Forum, we also technology; the economic opportunities decided, with your help, to launch two presented by longevity and implications key initiatives related to the mission of the for governments and individuals; the Forum. These were supporting research policy agenda supporting our educational, into scleroderma, a rare autoimmune healthcare and social care systems to disease, by leveraging Insilico Medicineʼs ensure they are fit for the future; a look next generation artificial intelligence, and at what is happening internationally; and, launching the Encore Fellows Scheme in Jim Mellon, Dafina Grapci-Penneyand Andrew Scott lastly,the relationship between humansand the UK to mentor retirees into new roles. Founders, The Longevity Forum machines and the governance framework We are excited about the progress made needed to ensure that this growing inter- in both areas and look forward to reporting dependence can help humans achieve this back to you as well as announce our When we set up the Forum,just over a year way for their implementation through our their full potential. 2020 projects. ago, our main objective was to facilitate the network of partners across diverse sectors exchange of ideas between experts from and countries. This approach remains core As ever, the quality of the speakers and As Longevity 2030, the theme of this the fields of science and social science to to our mission -which is to promote happier, the audience we have attracted this year yearʼs events attests, we are committed to explore the opportunities presented by healthier and more fulfilled lives for as many reflects the convening power of the Forum this mission for the long term and we are increases in humanlongevity. people as possible. across the worlds of government, business, excited about the opportunity to amplify the finance, research, academia and of NGOs. missionof the Forumthroughnew ideas and Our vision was to create a forum where To achieve this mission, the Forum aims to It is this growing network of individuals partnerships. We look forward to building cutting edge ideas would be generated, make these ideas accessible to all. This is and organisations whose interests are fully on the foundations of this weekʼs events debated and critiqued, thus paving the why raising awareness of the opportunities aligned with the goals of our mission that and continuing to foster such collaboration. www.thelongevityforum.com The Longevity Forum 2019 10.25 -10.50 Age Before Beauty? Examiningthe False Auditorium Dichotomy of Lifespan Versus Healthspan Dr Nir Barzilai PROGRAMME Founding Director, Institute for Aging at The Albert Ein- stein College of Medicine Aubrey de Grey Chief Science Officer of the SENS Research OF EVENTS Foundation Laura Deming Founder, The Longevity Fund 08.30 -09.00 Registration & Coffee The Grand Entrance 10.50 -11.20 Coffee Break The Library and Georgian Room 09.00 -09.15 Longevity 2030 -The Next Ten Years Auditorium Jim Mellon 11.20 -12.05 Panel: How Can the UK Add Five Years of Healthy Auditorium Co-Founder,The Longevity Forum Lifespan by 2030? Professor Andrew Scott Dr Charles Alessi Co-Founder,The Longevity Forum Chief Clinical Officer, HIMSS International Professor Lynne Cox Professor of Biochemistry, Oxford University 09.15-09.20 Beyond 100(video) Auditorium Tina Woods Barclays Private Bank CEO and Co-Founder,Longevity International Moderated by 09.20 -09.35 Keynote: Scientists, check. Investors, check. Auditorium Greg Bailey, MD Next up, policy-makers CEO, Juvenescence Limited Aubrey de Grey Chief Science Officer of the SENS Research Foundation 12.05 -13.00 Panel: Technologies shaping the future of humanity Auditorium over the next decade 09.35 -09.50 Keynote: Investing in Human Longevity Auditorium Camilla Cavendish, Baroness Cavendish of Little Venice Laura Deming Author of “Extra Time: Ten Lessons for an Ageing World” Founder, The Longevity Fund Professor Stephen Emmott Founder and CEO, Scientific Auditorium 09.50 -09.55 The Longevity Forum Projects: Scleroderma & James Lawford Davies Raynaudʼs UK Partner, Hill Dickinson LLP Polina Mamoshina Dr Ali Parsa Head of Biomarker Development, Insilico Medicine Founder and CEO, Babylon Health Anders Sandberg 09.55 -10.25 Keynote: How to Die Youngat a Very Old Age Auditorium Senior Research Fellow, Future of Humanity Institute, University of Oxford Dr Nir Barzilai Moderated by: Founding Director, Institute for Aging at The Albert Dafina Grapci-Penney Einstein College of Medicine Co-Founder,The Longevity Forum www.thelongevityforum.com The Longevity Forum 2019 Presentation: Bloomberg 2019Healthiest Country 13:00 -14.00 Lunch The Library/Georgian 16.20 -16.35 Auditorium Room Index Scott Johnson Economist, Bloomberg Economics 14:00 -14.30 Keynote: Realising the Opportunities of Longer Auditorium Lives Presentation: Working Together as We Work Longer: Auditorium Dr Linda P. Fried 16.35 -16.55 A Framework for Collaboration to Benefit from Lon- Dean, Mailman School of Public Health, Columbia gevity University Cynthia Brown Vice President, Operations & Finance, AARP 14.30 -14.35 The Longevity Forum Projects: Encore Fellows Auditorium UK 16.55 -17.15 Presentation: Age -the Grand Challenge Auditorium Julia Randell-Khan Senior Fellow, Encore.org Andy Briggs Co-Chair,UK Longevity Council 14.35 -14.40 Presentation: The Global Initiative Auditorium Joseph F. Coughlin Auditorium Director, the Massachusetts Institute of 17.15 -17.30 Closing Remarks: The Longevity Forum and Technology AgeLab Longevity Week Professor Andrew Scott, Dafina Grapci-Penney, 14.40 -15.40 The Longevity Dividend Panel Auditorium Jim Mellon Cynthia Brown 17.30 Drinks Reception The Library Vice President, Operations & Finance, AARP Professor David Miles, CBE Imperial College, London Gerald Moser Slido Chief Market Strategist, Barclays Private Bank Yvonne Sonsino Today, we will be using Slido to collect To register, go to slido.com on your phone Partner and Innovation Leader, Mercer questions and allow you to express your or download the app and type in code opinion in live polls. #longevityor use the QR Code below. Moderated by: Professor Andrew Scott Co-Founder,The Longevity Forum 15.40 -16.10 Afternoon Break The Library/Georgian Room Join at 16.10-16.20 Report: The Global Longevity Agenda Auditorium slido.com Professor Andrew Scott Co-Founder,The Longevity Forum #longevity www.thelongevityforum.com The Longevity Forum 2019 FOUNDERSOFTHELONGEVITYFORUM Andrew Scott Andrew Scott is Professor of Economics at London Business School and a Fellow of All Souls, Oxford University andtheCentre for Economic Policy Research. He previously held lecturing positions at Harvard University, FOUNDERS London School of Economics OF THE and University of Oxford. LONGEVITY Andrewʼsresearch focuses onthe economics our lives. He is currently investigating an of longevity and how individuals, corporates economic longevity dividend withthe support and governments need to adapt to seize of a £1mnESRC grant. FORUM the opportunities of long and healthier lives. Andrewʼs 2016 book “The 100 Year Life” He is a member of the advisory board of the on this theme was an award winning global UKʼs Office for Budget Responsibility and the best seller, translated into 15languages. His Cabinet Office Honours Committee (Science next book, ”A New Long Life”, is out in May and Technology)having previously served as 2020 and will look at how the twin forces of Non-Executive Director of the UKs Financial technology and longevity are set to change Services Authority 2009-13. TheThe Longevity Longevity ForumForum 2019 2019 FOUNDERSOFTHELONGEVITYFORUM FOUNDERSOFTHELONGEVITYFORUM Jim Mellon Dafina Grapci-Penney Jim is a
Load more

Recommended publications
  • Who Wants to Live Forever? Reader’S Digest
    HEALTH Who Wantsto Live Forever? As a species, we humans appear to be the undisputed masters of our planet. Moreover, since Yuri Gagarin’s inaugural space flight in 1961, we can even leave the confines of Earth to travel in space. Yet, we have one Achilles’ heel—we’re mortal BY CHRIS MENON 1234567890 1234567890 36 BRAIN LIGHT/ALAMY STOCK PHOTO WHO WANTS TO LIVE FOREVER? READEr’s DIGEST T 122 YEARS, THE MAXIMUM HUMAN LIFESPAN lags well behind some species of giant tortoise (188 years), Greenland shark (400 years) and the record set by the lowly Icelandic clam (507 years). Even those relatively few humans who do manage to make it past 100—some 14,570 people in the UK in 2015—are invariably bedeviled byA poor health. Recently, efforts to extend the healthy of Amazon, has similarly invested human lifespan have achieved much in Unity Biotechnology, which aims publicity following the backing of “to design therapeutics that prevent, visionary, super-rich Silicon Valley halt, or reverse diseases of ageing”. tech entrepreneurs. In 2013, Google’s Unity intends to develop a new founders created a subsidiary class of therapies called “senolytic company called Calico (short for medicines”, designed to selectively the California Life Company), eliminate senescent cells. Senescent Billionaire researchers, which promptly hired a team of top cells accumulate with age and, Some believe that death, Arthur Levinson, Jeff technologies that scientists and now has more than unlike normal cells, they secrete like any disease, can be Bezos and Elon Musk the SENS Research £1bn in the bank to fund its work.
    [Show full text]
  • From Here to Immortality: Anti-Aging Medicine
    FromFrom HereHere toto Immortality:Immortaalitty: AAnti-AgingAnnntti-AAgging MMedicineedicine Anti-aging medicine is a $5 billion industry. Despite its critics, researchers are discovering that inter ventions designed to turn back time may prove to be more science than fiction. By Trudie Mitschang 14 BioSupply Trends Quarterly • October 2013 he symptoms are disturbing. Weight gain, muscle Shifting Attitudes Fuel a Booming Industry aches, fatigue and joint stiffness. Some experience The notion that aging requires treatment is based on a belief Thear ing loss and diminished eyesight. In time, both that becoming old is both undesirable and unattractive. In the memory and libido will lapse, while sagging skin and inconti - last several decades, aging has become synonymous with nence may also become problematic. It is a malady that begins dete rioration, while youth is increasingly revered and in one’s late 40 s, and currently 100 percent of baby boomers admired. Anti-aging medicine is a relatively new but thriving suffer from it. No one is immune and left untreated ; it always field driven by a baby- boomer generation fighting to preserve leads to death. A frightening new disease, virus or plague? No , its “forever young” façade. According to the market research it’s simply a fact of life , and it’s called aging. firm Global Industry Analysts, the boomer-fueled consumer The mythical fountain of youth has long been the subject of base will push the U.S. market for anti-aging products from folklore, and although it is both natural and inevitable, human about $80 billion now to more than $114 billion by 2015.
    [Show full text]
  • Read Our New Annual Report
    The seeds of a concept. The roots of an idea. The potential of a world free of age-related disease. Photo: Sherry Loeser Photography SENS Research Foundation Board of Directors Barbara Logan, Chair Bill Liao, Secretary Kevin Perrott, Treasurer Michael Boocher Jonathan Cain Kevin Dewalt Michael Kope Jim O’Neill Frank Schüler Sherry Loeser Photography 2 Contents CEO Letter (Jim O’Neill) 4 Finances 5 Donors 6 - 7 Fundraising & Conferences 8 - 9 Around the World with Aubrey de Grey 10 Outreach 11 Founding CEO Tribute & Underdog Pharmaceuticals 12 - 13 Investments 14 Welcome New Team Members 15 Education 16 - 17 Publications & Research Advisory Board 18 Research Summaries 19 - 22 Ways to Donate 23 The SRF Team Front row: Anne Corwin (Engineer/Editor), Amutha Boominathan (MitoSENS Group Lead), Alexandra Stolzing (VP of Research), Aubrey de Grey (Chief Science Officer), Jim O’Neill (CEO), Bhavna Dixit (Research Associate). Center row: Caitlin Lewis (Research Associate), Lisa Fabiny-Kiser (VP of Operations), Gary Abramson (Graphics), Maria Entraigues-Abramson (Global Outreach Coordinator), Jessica Lubke (Administrative Assistant). Back row: Tesfahun Dessale Admasu (Research Fellow), Amit Sharma (ImmunoSENS Group Lead), Michael Rae (Science Writer), Kelly Protzman (Executive Assistant). Not Pictured: Greg Chin (Director, SRF Education), Ben Zealley (Website/Research Assistant/ Deputy Editor) Photo: Sherry Loeser Photography, 2019 3 From the CEO At our 2013 conference at Queens College, Cambridge, I closed my talk by saying, “We should not rest until we make aging an absurdity.” We are now in a very different place. After a lot of patient explanation, publication of scientific results, conferences, and time, our community persuaded enough scientists of the feasibility of the damage repair approach to move SENS and SENS Research Foundation from the fringes of scientific respectability to the vanguard of a mainstream community of scientists developing medical therapies to tackle human aging.
    [Show full text]
  • Longevity and Generosity. the Death of Death. July 2018. N° 112
    Longevity and generosity. The death of death. July 2018. N° 112. Some people say, “Oh, you shouldn’t do enhancement” but the thing is we do enhancement all the time — to some extent, all aging reversal is enhancement. ​ ​ ​ ​ Vaccines are enhancement… I think I’m just now getting up to speed after 63 years of education. Aging reversal is something that will buy me and many of my colleagues a lot more time to make many more contributions, so you might consider that a meta-level contribution, if we can pull that off. World-renowned ​ Harvard University biology researcher George Church (source). ​ ​ ​ ​ Theme of the month. How to contribute financially to research for a much longer healthy life Introduction If you have considerable financial means you can afford medical care more easily than less well-off citizens. But whether you are rich or not, with a good "genetic capital" or not, whatever your precautions and your anti-aging clinic visits, in the current state of knowledge your chances are low of living more than 100 years if you are a woman and beyond 95 years if you are of the weaker sex for longevity. And whatever happens, you will not live past 122 years for a ​ ​ woman et 116 years for a man. ​ ​ To go further will require complex and costly research. If informed citizens pay money to support this research, it will be positive in a direct way by funding the research. It will also be positive in that it will show the growing interest in these issues. What could you do about it? Moderate financial support If your financial means are limited or if you do not wish to make large donations, your action can still have an impact.
    [Show full text]
  • Ÿþc R Y O N I C S M a G a Z I N E , Q 1 2 0
    2007 RECAP 1st Quarter 2008 • Volume 29:1 2007 ANnual Review page 5 Member Profile: Wes Du Charme page 3 7th Alcor Conference Recap page 13 Cryonics and Religion: Friends or Foes? page 19 INSIDE CRYONICS 2 From the Editor 1ST QUARTER 2008 • VOLUME 29:1 19 Cryonics and Religion: Friends or Foes? The cryonics community recognizes the importance and challenge of being 1st Quarter 2008 • Volume 29:1 understood by the general 2007 RECAP public. Religion plays a sub- Cover shows opening reception stantial role in our diverse at the 7th Alcor conference. 2007 ANnual society and may seem to Review Photo by Brian Harris. page 5 some to be at odds with many facets of scientific COVER STORY: PAGE 5 advancement. Meet one theologian who feels the 2007 Annual Review: Today, over ultimate success of cryonics 850page people 3 in the world rely on the is contingent upon the sup- Member Profile: Wes Du CharmeAlcor Life Extension Foundation for Recap port of more than just great Conferencecryopreservation page 13 services. Enrich your 7th Alcor scientific minds. understanding of present-day clinical advancements with the potential to CryonicsFriends and Religion: or Foes?page 19 significantly benefit Alcor’s growing 22 Book Review: Ending membership base in years to come. Aging Likened to a good detective novel, Ending Aging allures the reader into a real- life tale of the mysteries of aging. The author, Dr. 3 Member Profile: Wes Du Charme Aubrey de Grey, has been Wes Du Charme – psychologist, author and barber shop quartet the center of controversy singer – celebrates his thirteenth year as an Alcor member in since proposing a systematic June 2008.
    [Show full text]
  • Blurring Our Edges
    NATURE|Vol 450|15 November 2007 BOOKS & ARTS not involve passing on truths from producer rigorous understanding of whose technical between colour perceivers and colour-blind to consumer, but takes the form of fallible expertise really should weigh in on techno- participants, probably because the latter had judgements made in situations in which all logical decision-making. This is what Collins been immersed since birth in the language of the desired information is not available. This and Evans call the “problem of extension”, or colour and acquired the ability to pass as per- applies to scientific collaborations and gov- “who is entitled to contribute to the technical ceivers. In another, judges could not pick out ernmental projects. “The speed of politics,” component of a technological decision”. If an Collins in a group of bona fide gravitational- they write in a characteristically succinct and extension is too technocratic, it will foster dis- wave researchers. clever remark, “exceeds the speed of scientific trust; if it is too broad, there is a risk of invoking These results have startling implications. consensus formation.” This leads them to ‘technological populism’, which means deci- For instance, Evans has shown that minorities defend their seemingly pedestrian conclusion sions could be overly influenced by politics or can acquire enough interactional expertise of that governments should rely on experts as lifestyle choice. mainstream culture to foil attempts to pick “the best way to distil human experience of an The authors address the problem of exten- them out by questioning alone. This suggests uncertain world” — even when those experts sion by offering a “periodic table of expertise” that if minorities live by different values, it is have no final answers.
    [Show full text]
  • SENS Research Foundation Annual Report 2015
    S E N S R e s e a r c h F o u n d a t i o n has a unique mission: to ensure the development of cures which repair the underlying cellular and molecular damage of aging. This document, our 2 0 1 5 R e p o r t, demonstrates our commitment to delivering on the promise of that mission, and to meeting the challenges facing the rapidly emerging rejuvenation biotechnology field. Our research program delivers key proof-of-concept results. Our education program prepares the first generation of rejuvenation biotechnology professionals. Our outreach program widens and connects our communi. Our Rejuvenation Biotechnology conferences unite stakeholders from academic, industrial, political, regulatory and financial institutions. Together, we are transforming the way the world researches and treats age-related disease. i n t r o d u c t i o n 2 l e t t e r f r o m t h e C E O 3 c o m m u n i t y 4 o u t r e a c h 6 e d u c a t i o n 8 r e s e a r c h 1 0 f i n a n c e s 1 4 r e s e a r c h : p r o j e c t b y p r o j e c t 1 5 s u p p o r t i n g t h e f o u n d a t i o n 2 3 FOUNDATION BOARD OF LEADERSHIP DIRECTORS Mike Kope Barbara Logan Jonathan Cain Chief Executive Officer Board Chair Kevin Dewalt Kevin Perrott Dr.
    [Show full text]
  • Why We Should Reject Radical Enhancement.1
    A peer-reviewed electronic journal published by the Institute for Ethics and Emerging Technologies ISSN 1541-0099 21(2) - November 2010 Thoughts about our species’ future: themes from Humanity’s End: Why We Should Reject Radical Enhancement.1 Nicholas Agar Philosophy, Victoria University of Wellington [email protected] Journal of Evolution and Technology - Vol. 21 Issue 2 – November 2010 - pgs 23-31 http://jetpress.org/agar.htm Abstract This paper summarizes a couple of the main arguments from my new book, Humanity’s End. In the book I argue against radical enhancement – the adjustment of human attributes and abilities to levels that greatly exceed what is currently possible for human beings. I’m curious to see what reaction this elicits in a journal whose readership includes some of radical enhancement’s most imaginative and committed advocates. Humanity’s End is motivated by the conviction that the debate about human enhancement must move beyond the binary “yes, I love it; no, it’s evil” dialectic that has tended to dominate philosophical discussion up till now. When we focus on the multiple means – cybernetic, genetic, nanotechnological, and so on – by which humans are likely to be enhanced, we find significant moral differences. Some human enhancements should be endorsed; many should be rejected. An additional motivation for Humanity’s End is a sense that the technologies of human enhancement are on the verge of something really big. If Ray Kurzweil is right, then improvements of the information technologies that may be used to enhance human attributes track an exponential path (Kurzweil 2005).
    [Show full text]
  • Do Actuaries Believe in Longevity Deceleration? Edouard Debonneuil, Stéphane Loisel, Frédéric Planchet
    Do actuaries believe in longevity deceleration? Edouard Debonneuil, Stéphane Loisel, Frédéric Planchet To cite this version: Edouard Debonneuil, Stéphane Loisel, Frédéric Planchet. Do actuaries believe in longevity decelera- tion?. 2015. hal-01219270v2 HAL Id: hal-01219270 https://hal.archives-ouvertes.fr/hal-01219270v2 Preprint submitted on 5 Aug 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. DO ACTUARIES BELIEVE IN LONGEVITY DECELERATION? Edouard Debonneuil Stéphane Loisel Frédéric Planchet* Univ Lyon - Université Claude Bernard Lyon 1, ISFA, Laboratoire SAF EA2429, F-69366, Lyon, France Prim’Act, 42 avenue de la Grande Armée, 75017 Paris, France ActuRx Version 2.0 du 05/08/2017 ABSTRACT As more and more people believe that significant life extensions may come soon, should commonly used future mortality assumptions be considered prudent? We find here that commonly used actuarial tables for annuitants – as well as the Lee-Carter model – do not extrapolate life expectancy at the same rate for future years as for past years; instead they produce some longevity deceleration. This is typically because their mortality improvements decrease after a certain age, and those age-specific improvements are constant over time.
    [Show full text]
  • Sample Chapter [PDF]
    THE PHILOSOPHY OF TRANSHUMANISM This page intentionally left blank THE PHILOSOPHY OF TRANSHUMANISM ACriticalAnalysis BENJAMIN ROSS University of North Texas, USA United Kingdom – North America – Japan – India Malaysia – China Emerald Publishing Limited Howard House, Wagon Lane, Bingley BD16 1WA, UK First edition 2020 © 2020 Benjamin Ross Published under exclusive licence by Emerald Publishing Limited Reprints and permissions service Contact: [email protected] No part of this book may be reproduced, stored in a retrieval system, transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without either the prior written permission of the publisher or a licence permitting restricted copying issued in the UK by The Copyright Licensing Agency and in the USA by The Copyright Clearance Center. Any opinions expressed in the chapters are those of the authors. Whilst Emerald makes every effort to ensure the quality and accuracy of its content, Emerald makes no representation implied or otherwise, as to the chapters’ suitability and application and disclaims any warranties, express or implied, to their use. British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library ISBN: 978-1-83982-625-2 (Print) ISBN: 978-1-83982-622-1 (Online) ISBN: 978-1-83982-624-5 (Epub) CONTENTS Introduction 1 1. Redesigning Humans 5 1.1. Transhumanist Philosophy I: Summoning the Posthuman 7 1.2. Transhumanist Philosophy II: Epistemological Certainty 13 1.3. Resisting Transhumanism: Bioconservative Views 18 1.4. The Language of Enhancement through the Lens of Automation 25 2. Engaging with Transhumanism 37 2.1.
    [Show full text]
  • SENS Research Foundation Annual Report 2014
    sens research foundation foundation report august 2014 mission 2 leer from the CEO 3 outreach 4 research 8 education 14 finances 16 research: project by project 18 FOUNDATION BOARD OF LEADERSHIP DIRECTORS Mike Kope Barbara Logan Jonathan Cain Chief Executive Officer Board Chair Kevin Dewalt Kevin Perrott Aubrey de Grey Treasurer James O’Neill Chief Science Officer Bill Liao Mike Kope Secretary © 2014, SENS Research Foundation a: 110 Pioneer Way, Suite J / Mountain View, CA 94041 / USA p: 650.336.1780 f: 650.336.1781 www.sens.org All rights reserved. No part of this material may be reproduced without specific permission from SENS Research Foundation. SENS Research Foundation’s federal employer ID number is 94-3473864. Because SENS Research Foundation is a 501(c)(3) non-profit, your donation may be tax deductible. transforming the way the world researches and treats age-related disease We fund research at institutions around the world, and at our own Moun- tain View facility. Our research is integrated with wide-ranging outreach and education programs. Our goal is to see the emergence of an industry that will cure the diseases of aging, an industry based around what we call rejuvenation biotechnology. Many things go wrong with aging bodies, but at the root of them all is the burden of decades of unrepaired damage to the cellular and molecular structures that make up the functional units of our tissues. Faced with the diseases and disabilities caused by this damage, today’s medicine is too often reduced to crisis management in the emergency room, painfully harsh treatments for diseases such as cancer, or best efforts at palliative care.
    [Show full text]
  • Issue 139. October 2020
    NEWSLETTER HEALES The most well-known longevitists | October 2020 | N°139 | The death of death I, personally, if there are technologies that can extend my life, and I have access to them, yes, I would choose to use them. But I also think that there are going to be individual questions because in the name of this freedom, we are also going to create inequalities between human beings. (...) There is going to be a radical moment (by) the conjunction between gene therapy and nanotechnology (...) which means that we are going to have treatments that are not only extremely effective in treating diseases related to aging, but also perhaps even in halting aging. Corinne Narassiguin, French politician, number 2 of the Socialist Party, talking notably about possible ways of making these therapies accessible one day to all those who wish to have them. ___________________________________________________________ Theme of the month: The most well-known longevitists ___________________________________________________________ Obviously, the choice below is subjective. It is an overview of some of the women and men committed to making a much longer and healthier life possible. They have expressed themselves behind their test tubes, in their academic research, but also in front of cameras. The diversity of their approaches illustrates the difficulty and richness of the work in this field that concerns us all. Aubrey De Grey Aubrey de Grey is an English scientist, former computer scientist at the University of Cambridge and was initially self-taught in bio-gerontology. He now lives in California. Inspired by Dr Denham Harman's 1972 "Mitochondrial Theory of Aging", he developed a project called SENS (Strategies for Engineered Negligible Senescence) to prevent age-related physical and mental decline.
    [Show full text]